ScienceDaily

One CRISPR treatment cut “bad” cholesterol in half for a full year

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.

作者 ScienceDaily

1 分钟阅读
One CRISPR treatment cut “bad” cholesterol in half for a full year
One CRISPR treatment cut “bad” cholesterol in half for a full year

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Medical Science相关内容

相关洞察